Zealand Pharma
Headquarters country
Denmark
Registry sponsor category
Industry
- Other names
- Zealand Pharma
- Company name
- Zealand Pharma
- Organisation type
- Industry
- Registered legal name
- ZEALAND PHARMA A/S
- Registry sponsor category
- Industry
- Website
- https://www.zealandpharma.com/
- Legal Entity Identifier (LEI)
- 549300ITBB1ULBL4CZ12
- Wikidata ID
- Q18552286
Related records
Trials (49)
- A Bridging Trial to Compare the PK Profile When Glepaglutide is Administered Via Vial/Syringe Versus Autoinjector.
- A Dose-Finding Study of Petrelintide With Enicepatide (RO7795068) in Adults With Obesity or Overweight
- A First-in-human Study Looking at the Safety of ZP8396 and How it Works in the Body of Healthy Trial Participants
- A Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570
- A Phase 2 Trial Testing ZP1848 in Patients With SBS
- A Research Study Looking at the Safety of Multiple Doses of ZP8396 and How it Works in the Body of Healthy Participants
- A Research Study Looking at the Safety of Single and Multiple Doses of ZP9830 and How it Works in the Body of Healthy Participants
- A Single and Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP6590 in Participants With Normal Weight, Overweight and Obesity
- A Single Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570
- A Study to Inv. Safety, Efficacy & PD of Dasiglucagon as Hypoglycemia Rescue Therapy in Children <6 Years With T1D
- A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570
- A Trial Comparing Pharmacokinetics, Safety and Tolerability of Two Subcutaneous Concentrations of Dapiglutide
- A Trial to Compare the Efficacy and Safety of 2 Different Batches of Subcutaneous Dasiglucagon in Patients With T1DM
- A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects
- A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus
- A Trial to Understand How Safe and Well Tolerated ZP9830 is and How it Works in People With Plaque Psoriasis Over an 8-week Treatment Period
- A Two-Period Open-label Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism
- Dapiglutide for the Treatment of Obesity
- Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
- Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome